Isotherapeutics Group LLC Angleton, TX - 77515

Isotherapeutics Group LLC is categorized under Chemists-Analytical and Consulting in Angleton, TX and active since 2005.

Isotherapeutics Group LLC was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Chemists-Analytical and Consulting business, which does work in the B2B market, and is classified as a Chemists-Analytical and Consulting, under code number 5417115 by the NAICS.

If you are seeking more information, feel free to contact Jim Simon, Owner at the company’s single location by writing to 1004 South Velasco St, Angleton, Texas TX 77515 or by phoning (979) 848-0800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Isotherapeutics Group LLC
Contact Person: Jim Simon, Owner
Address: 1004 South Velasco St, Angleton, Texas 77515
Phone Number: (979) 848-0800
Website Address: isotherapeutics.com
Annual Revenue (USD): Unknown
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Chemists-Analytical and Consulting
SIC Code: 8999
NAICS Code: 5417115
Share This Business:

Isotherapeutics Group LLC was started in 2005 to provide professional Chemists-Analytical and Consulting under the SIC code 8999 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Jim Simon, Owner for inquiries that concern Isotherapeutics Group LLC by calling the company number (979) 848-0800, as your correspondence is most welcome. Additionally, the physical location of the single location of Isotherapeutics Group LLC can be found at the coordinates 29.15509,-95.43109 as well as the street address 1004 South Velasco St in Angleton, Texas 77515.

For its online presence, you may visit Isotherapeutics Group LLC’s website at isotherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.